Mei Shi Selected Research

Peptaibols

5/2014	Trichokonins from Trichoderma pseudokoningii SMF2 induce resistance against Gram-negative Pectobacterium carotovorum subsp. carotovorum in Chinese cabbage.
12/2010	Antimicrobial peptaibols induce defense responses and systemic resistance in tobacco against tobacco mosaic virus.
2/2010	Antimicrobial peptaibols, novel suppressors of tumor cells, targeted calcium-mediated apoptosis and autophagy in human hepatocellular carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mei Shi Research Topics

Disease

24	Neoplasms (Cancer) 02/2022 - 01/2002
16	Nasopharyngeal Carcinoma 01/2022 - 01/2012
15	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 02/2011
12	Infections 01/2020 - 01/2005
10	Breast Neoplasms (Breast Cancer) 02/2022 - 02/2010
8	Neurosyphilis (General Paresis of the Insane) 01/2022 - 01/2014
8	Lymphoma (Lymphomas) 01/2021 - 01/2018
7	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021 - 04/2015
6	Syphilis 01/2022 - 01/2014
6	Neoplasm Metastasis (Metastasis) 07/2021 - 10/2016
4	Triple Negative Breast Neoplasms 02/2022 - 08/2011
4	Neutropenia 01/2021 - 01/2017
4	Carcinoma (Carcinomatosis) 01/2018 - 01/2013
3	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 03/2017
3	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2021 - 01/2014
3	Proteinuria 01/2021 - 01/2013
3	Hepatocellular Carcinoma (Hepatoma) 04/2013 - 02/2008
2	secondary Syphilis 11/2021 - 05/2018
2	Latent Syphilis 11/2021 - 05/2018
2	primary Syphilis 11/2021 - 05/2018
2	Extranodal NK-T-Cell Lymphoma 01/2021 - 10/2018
2	Esophageal Squamous Cell Carcinoma 01/2020 - 01/2017
2	Anemia 01/2019 - 01/2012
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2018 - 10/2013
2	Wounds and Injuries (Trauma) 07/2017 - 02/2008
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2016 - 11/2015
2	Squamous Cell Carcinoma of Head and Neck 08/2015 - 01/2013
2	Glomerulonephritis 01/2014 - 01/2013
2	Virus Diseases (Viral Diseases) 07/2013 - 12/2010
2	Hypoxia (Hypoxemia) 02/2011 - 01/2007
1	Brain Injuries (Brain Injury) 08/2022
1	Vascular Diseases (Vascular Disease) 08/2022
1	Vascular System Injuries 08/2022
1	Stroke (Strokes) 08/2022
1	Ischemic Stroke 08/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2022
1	Pre-Eclampsia (Preeclampsia) 12/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2021
1	Inflammation (Inflammations) 01/2021

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2007
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2005
5	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 08/2015
4	CytokinesIBA 01/2021 - 07/2013
4	AnthracyclinesIBA 01/2021 - 12/2018
3	Gemcitabine FDA Link 01/2022 - 01/2019
3	Pharmaceutical PreparationsIBA 01/2020 - 07/2006
3	TabletsIBA 01/2018 - 01/2013
3	Transcription Factors (Transcription Factor)IBA 12/2014 - 01/2007
3	Interleukin-2 (IL2)IBA 12/2014 - 07/2013
3	Interleukin-10 (Interleukin 10)IBA 06/2014 - 11/2012
3	PeptaibolsIBA 05/2014 - 02/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2013 - 01/2007
3	SurvivinIBA 02/2011 - 01/2007
2	4-iodobenzenesulfonamideIBA 01/2022 - 12/2019
2	Treponema pallidum 47-kDa immunogenIBA 11/2021 - 05/2018
2	Messenger RNA (mRNA)IBA 01/2021 - 02/2011
2	CateninsIBA 01/2020 - 03/2012
2	Sincalide FDA Link 01/2020 - 02/2018
2	HMGB1 Protein (HMG1)IBA 01/2020 - 01/2020
2	Immunoglobulin G (IgG)IBA 11/2019 - 12/2013
2	MicroRNAs (MicroRNA)IBA 01/2019 - 05/2014
2	PlatinumIBA 01/2019 - 08/2015
2	LuciferasesIBA 01/2019 - 02/2018
2	Asparaginase (Elspar)FDA Link 10/2018 - 04/2015
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 01/2014
2	Interleukin-17 (Interleukin 17)IBA 06/2015 - 01/2014
2	Antiviral Agents (Antivirals)IBA 01/2015 - 01/2013
2	Interleukin-12 (IL 12)IBA 12/2014 - 06/2014
2	Interleukin-6 (Interleukin 6)IBA 12/2014 - 06/2014
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2014 - 03/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2014 - 03/2014
2	Interleukin-4 (Interleukin 4)IBA 07/2013 - 11/2012
2	Eukaryotic Initiation Factor-4EIBA 07/2012 - 02/2011
2	Peptide Initiation Factors (Initiation Factor)IBA 07/2012 - 02/2011
2	Hormones (Hormone)IBA 08/2011 - 05/2003
2	Biological ProductsIBA 06/2011 - 01/2007
1	Peroxidase (Myeloperoxidase)IBA 08/2022
1	Phenobarbital (Luminal)FDA Link 02/2022
1	TocotrienolsIBA 12/2021
1	Vitamin E FDA LinkGeneric 12/2021
1	Indicators and Reagents (Reagents)IBA 11/2021
1	C-PeptideIBA 11/2021
1	Bevacizumab (Avastin)FDA Link 07/2021
1	Polystyrenes (Polystyrene)IBA 01/2021
1	Capecitabine (Xeloda)FDA Link 01/2021

Therapy/Procedure

37	Radiotherapy 02/2022 - 01/2007
15	Drug Therapy (Chemotherapy) 06/2021 - 08/2011
14	Chemoradiotherapy 01/2022 - 01/2013
12	Therapeutics 01/2022 - 01/2005
9	Induction Chemotherapy 01/2022 - 01/2017
5	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 06/2021 - 01/2012
4	Brachytherapy 01/2018 - 09/2011
3	Aftercare (After-Treatment) 11/2021 - 01/2002
3	Adjuvant Chemotherapy 06/2021 - 08/2011
3	Mastectomy (Mammectomy) 01/2021 - 08/2011
3	Neoadjuvant Therapy 01/2021 - 11/2015
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2013 - 09/2011
1	Modified Radical Mastectomy (Mastectomy, Modified) 02/2022
1	Immunotherapy 01/2022